Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From CellGenix GmbH
Although the US sports medicine market is dominated by conservative care treatments, new surgical techniques, arthroscopy products and surgical implants are fueling growth in the market, which is projected to reach almost $15.5 billion by 2018. Industry consolidation and dealmaking among orthopedic manufacturers has yielded several partnerships and M&As that have included a sports medicine element.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
- CellGenix Technologie Transfer GmbH
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.